Notice Number: NOT-DA-15-061

Key Dates
Release Date: March 24, 2015

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to revise the age range of the current funding opportunity announcement (FOA) PA-15-035 "Research Aimed at Novel Behavioral Targets to Improve Adolescent Substance Abuse Treatment and Prevention Interventions (R01)" which was published on November 18, 2014.  The original FOA specified inclusion of adolescents. The current revision extends the inclusionary age range to 25 years old based on emerging data on brain development that suggests the brain may not reach full maturity until early or mid-20s (years of age), and because substance use disorders may not emerge until young adulthood. This revision will allow for individual variation in brain development up through a time period when predictable brain development has stabilized.

Part 2. Section I. Funding Opportunity Description

Purpose
Currently reads: Areas supported by this FOA include research to inform the generation and refinement of novel substance abuse treatment and prevention interventions, modules, or adjuncts to existing treatments and prevention interventions that seek to target and modulate behavioral and/or neurobehavioral processes (e.g., impulsivity, risk-taking propensity, sensation and novelty seeking, distress tolerance, delay discounting, self-regulation, stress reactivity) in adolescents.

Modified to read: Areas supported by this FOA include research to inform the generation and refinement of novel substance abuse treatment and prevention interventions, modules, or adjuncts to existing treatments and prevention interventions that seek to target and modulate behavioral and/or neurobehavioral processes (e.g., impulsivity, risk-taking propensity, sensation and novelty seeking, distress tolerance, delay discounting, self-regulation, stress reactivity) in adolescents and young adults (up to 25 years old).

All other aspects of PA-15-035 remain unchanged.

Inquiries

Please direct all inquiries to:

Will M. Aklin, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-3207
Email: [email protected]

Geetha Subramaniam, M.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-0974
Email: [email protected]

Brett Hagman, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-0638
Email: [email protected]

Annette Kaufman, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6706
Email: [email protected]